Menoza, Neljon Fel G.

HRN: 22-40-37  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/31/2022
CEFUROXIME 750MG (VIAL)
12/31/2022
01/07/2023
IV
750mg
Q8h
Fracture, Laceration, Abrasion
Waiting Final Action 
01/12/2023
CEFUROXIME 750MG (VIAL)
01/12/2023
01/14/2023
IV
1.5g
Q8
Fracture, Femur, S/p ORIF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: